Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 27;14(8):e28468.
doi: 10.7759/cureus.28468. eCollection 2022 Aug.

Influence of Subclinical Hypothyroidism on Women With Polycystic Ovary Syndrome: A Literature Review

Aishwarya Peddemul  1 , Sreedevi Tejovath  2 , Danial Hassan  3   4 , Khushbu K Patel  2 , Rabia Sikandar  2 , Simranjit S Kahlon  2 , Shaalina Nair  2 , Jihan A Mostafa  2
Affiliations
Review

Influence of Subclinical Hypothyroidism on Women With Polycystic Ovary Syndrome: A Literature Review

Aishwarya Peddemul et al. Cureus. .

Abstract

Subclinical hypothyroidism (SCH) is a commonly encountered condition in women with polycystic ovary syndrome (PCOS). Nevertheless, it is unclear whether SCH has any potential impact on the metabolic and reproductive profiles of women with PCOS. Hence, this literature review explores and establishes the link between these two conditions. In women with PCOS, SCH was found to aggravate insulin resistance and dyslipidemia. It was also linked to hormonal imbalances leading to higher infertility rates among the PCOS-SCH group. Therefore, women with PCOS must be screened for thyroid function frequently and managed accordingly.

Keywords: dyslipidemia; female infertility; homeostatic model assessment of insulin resistance (homa-ir); polycystic ovary syndrome (pcos); subclinical hypothyroidism.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Common clinical findings between PCOS and subclinical hypothyroidism
PCOS, polycystic ovary syndrome Figure created by the authors
Figure 2
Figure 2. Mechanism of insulin resistance and other clinical features of PCOS
PCOS, polycystic ovary syndrome Figure created by the authors
Figure 3
Figure 3. Mechanism of anovulation and infertility in PCOS
LDL, low-density lipoprotein; TG, triglycerides; FFA, free fatty acids Figure created by the authors
Figure 4
Figure 4. Management of infertility in PCOS
PCOS, polycystic ovary syndrome; SCH, subclinical hypothyroidism; TSH, thyroid-stimulating hormone [37-39] Figure created by the authors
See this image and copyright information in PMC

References

    1. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. Hum Reprod. 2010;25:544–551. - PubMed
    1. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Teede HJ, Misso ML, Deeks AA, et al. Med J Aust. 2011;195:0–112. - PubMed
    1. Apa-I polymorphism in VDR gene is related to metabolic syndrome in polycystic ovary syndrome: a cross-sectional study. Santos BR, Lecke SB, Spritzer PM. Reprod Biol Endocrinol. 2018;16:38. - PMC - PubMed
    1. Obesity and cancer: evidence, impact, and future directions. Colditz GA, Peterson LL. Clin Chem. 2018;64:154–162. - PubMed
    1. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fauser BC, Tarlatzis BC, Rebar RW, et al. Fertil Steril. 2012;97:28–38. - PubMed

LinkOut - more resources